|
|
|
Quick Links
NCRR and the 2009 Recovery Act
|
NCRR Funds Two New Biomedical Technology Centers, October 2008BT Highlights
Single-Molecule Experiments in Vitro and in Silico Biomedical Technology Research Centers (BTRCs) create critical, often unique technology and methods at the forefront of their respective fields, and apply them to a broad range of basic, translational, and clinical research. This is accomplished through a synergistic interaction of technical and biomedical expertise, both within the resources and through intensive collaborations with other leading laboratories. BTRCs serve a unique purpose in the broad context of NIH-funded research. They represent a critical mass of technological and intellectual resources with a strong focus on service and training for outside investigators, as well as dissemination of technologies, methods, and software. Their goal is to promote the widespread and routine application of the cutting-edge technologies they develop across the full spectrum from bench to bedside. The Northern California Institute for Research and Education, Inc.San Francisco
Resource for MRI of Neurodegenerative Disorders
Principal Investigator Description (provided by grantee):The overall goal of this new resource is to develop, optimize and validate innovative magnetic resonance imaging (MRI) techniques for better diagnosis, early detection, assessment of treatment interventions, monitoring progression, and investigations in to the causes of neurodegenerative diseases. These techniques, which include improved MRI/magnetic resonance spectroscopy (MRS) acquisition, image reconstruction, and processing/analysis, will improve disease detection through brain imaging. This effort is a collaboration among MRI physicists, computer scientists and clinical investigators aimed at a single theme: neurodegenerative diseases. Specific aims of the resource are to develop, improve and test:
Resource staff will implement these improvements in collaborative projects and provide training for investigators and staff. This project is significant, in that prevalence of neurodegenerative diseases is rapidly increasing due to aging of the population, and methods for early detection are urgently needed. Treatments for these diseases are under development, and sensitive methods to determine treatment response are required. University of California, San DiegoLaJolla Center for Computational Mass Spectrometry
Principal Investigator Description (provided by grantee):This center in computational mass spectrometry will be a national and international resource in proteomics. The current computational bottleneck in the proteomics community impairs interpretation of data in thousands of experimental laboratories. The center's goal is to bring modern algorithmic technologies to mass spectrometry and build a new generation of reliable open-access software tools to support new instrumentation development and emerging applications. The center will focus on:
These four goals cover unexplored problems as well as well-studied but still inadequately addressed issues. Important collaborations already exist among the University of California, San Diego and the Burnham Institute; 16 other U.S. universities, hospitals, and biotechnology companies; and foreign research institutions. Further development of robust open-access mass spectrometry software will catalyze the exchanges between experimental and computational researchers in proteomics. The biomedical applications addressed in these collaborative projects include:
Educational activities will also be developed, including short courses, a seminar program, and an annual conference. Contact Information
For information on grant funding programs that support new research resources, refer to the Guidelines
for Biomedical Technology Programs (82KB PDF file, requires free Acrobat Reader
Michael T. Marron, Ph.D. |
| National Institutes of Health (NIH) Bethesda, Maryland 20892 |
Department of Health and Human Services |